Cargando…

Paired Measurements of Paraoxonase 1 and Serum Amyloid A as Useful Disease Markers

Paraoxonase 1 (PON1) and serum amyloid A (SAA) are proteins carried by high-density lipoprotein (HDL) particles. Among the HDL-associated protein molecules, SAA, an inflammation-related marker, and PON1, an antioxidant marker, tend to change in relatively clear opposite directions in physiological s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kotani, Kazuhiko, Yamada, Toshiyuki, Gugliucci, Alejandro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2013
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3818810/ https://www.ncbi.nlm.nih.gov/pubmed/24228251 http://dx.doi.org/10.1155/2013/481437

Ejemplares similares

Serum paraoxonase activity in familial hypercholesterolaemia
por: Kotani, Kazuhiko, et al.
Publicado: (2023)

Paraoxonase 1 in Chronic Kidney Failure
por: Gugliucci, Alejandro, et al.
Publicado: (2012)

Paraoxonase 1 and Chronic Kidney Disease: A Meta-Analysis
por: Watanabe, Jun, et al.
Publicado: (2023)

Paraoxonase 1 and Chronic Obstructive Pulmonary Disease: A Meta-Analysis
por: Watanabe, Jun, et al.
Publicado: (2021)

Paraoxonase 1 and Non-Alcoholic Fatty Liver Disease: A Meta-Analysis
por: Kotani, Kazuhiko, et al.
Publicado: (2021)

Paraoxonase 1, HDL Subclasses and Post Surgery Acute Inflammation: A Pilot Study
por: Bains, Yasmin, et al.
Publicado: (2019)

Paraoxonase 1 Activity and Renal Replacement Therapy for Chronic Renal Failure: A Meta-Analysis
por: Watanabe, Jun, et al.
Publicado: (2023)

Serum cholesterol concentration associated with aspirin esterase activity in older people: preliminary data
por: Kotani, Kazuhiko, et al.
Publicado: (2010)

Changes on the Physiological Lactonase Activity of Serum Paraoxonase 1 by a Diet Intervention for Weight Loss in Healthy Overweight and Obese Women
por: Kotani, Kazuhiko, et al.
Publicado: (2009)

Influence of Polymorphism on Glycosylation of Serum Amyloid A4 Protein
por: Yamada, Toshiyuki, et al.
Publicado: (2014)

Influence of Physical Activity Intervention on Circulating Soluble Receptor for Advanced Glycation end Products in Elderly Subjects
por: Kotani, Kazuhiko, et al.
Publicado: (2011)

Serum paraoxonase 1 (PON1) measurement: an update
por: Ceron, Jose J, et al.
Publicado: (2014)

Serum aspirin esterase is strongly associated with glucose and lipids in healthy subjects: different association patterns in subjects with type 2 diabetes mellitus
por: Kotani, Kazuhiko, et al.
Publicado: (2010)

Similarity and differences in small dense low-density lipoprotein assessment: two methods compared
por: Kotani, Kazuhiko, et al.
Publicado: (2021)

Usefulness of the Measurement of Serum Paraoxonase-1 Arylesterase Activity in the Diagnoses of COVID-19
por: Gabaldó, Xavier, et al.
Publicado: (2022)

Paraoxonase/Arylesterase Activity of Serum Paraoxonase-1 and Schizophrenia: A Systematic Review and Meta-Analysis
por: Zinellu, Angelo, et al.
Publicado: (2023)

Factors associated to serum paraoxonase 1 activity in patients with cardiovascular disease
por: Longo, Aline, et al.
Publicado: (2021)

Active Site Hydrophobicity and the Convergent Evolution of Paraoxonase Activity in Structurally Divergent Enzymes: The Case of Serum Paraoxonase 1
por: Blaha-Nelson, David, et al.
Publicado: (2016)

The effect of homocysteine thiolactone on paraoxonase and aryl esterase activity of human serum purified paraoxonase 1 in vitro experiments
por: Moshtaghie, Elham, et al.
Publicado: (2022)

Association of serum paraoxonase enzyme activity and oxidative stress markers with dyslipidemia in obese adolescents
por: Zaki, Moushira Erfan, et al.
Publicado: (2014)

Reduced Paraoxonase 1 Activity as a Marker for Severe Coronary Artery Disease
por: Zhou, Chiyan, et al.
Publicado: (2013)

Homocysteinethiolactone and Paraoxonase: Novel markers of diabetic retinopathy
por: Barathi, Subramaniam, et al.
Publicado: (2010)

High Prevalence of Low Serum Paraoxonase-1 in Subjects with Coronary Artery Disease
por: Jayakumari, Narayani, et al.
Publicado: (2009)

Serum paraoxonase and malondialdehyde levels in asymptomatic cholelithiasis
por: Agilli, Mehmet, et al.
Publicado: (2014)

Serum Paraoxonase as an Indicator for Fatty Liver in Sheep
por: Cao, Yu, et al.
Publicado: (2017)

Serum Paraoxonase 1 Activity Status in Patients with Liver Disorders
por: Kedage, Vivekananda, et al.
Publicado: (2010)

Serum paraoxonase 1 activity in patients with iron deficiency anemia
por: Okuturlar, Yildiz, et al.
Publicado: (2016)

Paraoxonase 1 and atherosclerosis
por: Durrington, Paul N., et al.
Publicado: (2023)

Correlation of Ischemia-Modified Albumin with SOFA and APACHE II Scores in Preoperative Patients with Colorectal Cancer
por: Satoh, Masaaki, et al.
Publicado: (2014)

The Structure and Function of Paraoxonase-1 and Its Comparison to Paraoxonase-2 and -3
por: Taler-Verčič, Ajda, et al.
Publicado: (2020)

Low serum paraoxonase1 activity levels predict coronary artery disease severity
por: Sun, Ting, et al.
Publicado: (2016)

Serum Paraoxonase-1 Activity in Prostate Cancer Patients Treated with Brachytherapy as a Measure of Irradiation Efficacy
por: Olszewska-Słonina, Dorota, et al.
Publicado: (2023)

Theoretical Studies on Catalysis Mechanisms of Serum Paraoxonase 1 and Phosphotriesterase Diisopropyl Fluorophosphatase Suggest the Alteration of Substrate Preference from Paraoxonase to DFP
por: Zhang, Hao, et al.
Publicado: (2018)

Suppression of inflammatory arthritis in human serum paraoxonase 1 transgenic mice
por: Charles-Schoeman, Christina, et al.
Publicado: (2020)

Response to: Serum Paraoxonase and Malondialdehyde Levels in Asymptomatic Cholelithiasis
por: Atamer, Aytaç, et al.
Publicado: (2016)

Correlation of Paraoxonase-1 with the Severity of Crohn’s Disease
por: Szczeklik, Katarzyna, et al.
Publicado: (2018)

Phytochemicals as Modulators of Paraoxonase-1 in Health and Diseases
por: Arab, Zahra Najafi, et al.
Publicado: (2022)

Considering the inter-assay harmonization status of ferritin measurements when using serum ferritin for research on COVID-19
por: Kotani, Kazuhiko
Publicado: (2022)

The association between adiponectin, HDL-cholesterol and α1-antitrypsin-LDL in female subjects without metabolic syndrome
por: Kotani, Kazuhiko, et al.
Publicado: (2010)

Arylesterase Activity of Paraoxonase-1 in Serum and Cerebrospinal Fluid of Patients with Alzheimer’s Disease and Vascular Dementia
por: Romani, Arianna, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_tfdudl2k7k7udl5id7p50g4s7a